Top-Secret Military Base in New Mexico Desert
Out in the New Mexico desert sits a top secret government facility... The scientists here are studying a new technology that will change the way wars are fought... Once you see this thing for yourself -- you'll know in your heart it could be coming for all of us. That's why I've taken steps to help protect myself and my family from what could be unleashed as early as April 11.
Financials
| Curr Year EPS Estimate | -5.27 |
| Next Quarter EPS Estimate | -1.42 |
| Profit Margin | -1212.19% |
| Operating Margin | -1,247.99 |
| Return on Assets | -0.28 |
| Return on Equity | -0.52 |
| Revenue | 43.1M |
| Earnings Per Share | -5.45 |
| Revenue Per Share | 0.45 |
| Gross Profit | -415,328,992 |
| Quarterly Revenue Growth | -0.24 |
General
| Name | Intellia Therapeutics Inc |
| Ticker | NTLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 526 |
About Intellia Therapeutics Inc
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Earnings
NASA's 2 stuck astronauts take their first spacewalk together
CAPE CANAVERAL, Fla. (AP) — NASA’s took their first spacewalk together Thursday, exiting the International Space Station almost eight months after moving in.
Elon Musk Is 'Kind Of Glad' Many Didn't Pick Up A Tesla FSD Subscription: Here's Why
Tesla Inc CEO Elon Musk said on Wednesday that the company will likely have to update hardware for customers whose vehicles are equipped with an older version of the AI hardware called Hardware 3, for it to achieve fully unsupervised autonomous driving with full self-driving (FSD) driver assistance software.
2025's No. 1 Trump Era Trade - Ad
Elon Musk is warning about a major shortage we will face in 2025. Trump is targeting one specific resource as the solution to the problem. One American company is virtually the only company set up to solve this situation... generating billions in sales.
Nvidia faces a reckoning as an upstart rival raises questions about Wall Street's darling
NEW YORK (AP) — The superstar run for Nvidia’s stock the last few years has been astonishing. So was its tumble Monday, which caused $595 billion in wealth to vanish. That’s about as much as PepsiCo, McDonalds, Starbucks and Target are worth, combined.
What to know about Trump's buyout proposal for federal employees
President Donald Trump's administration is offering to federal employees to quickly reduce the government workforce. They don't have a long time to decide: The deadline is Feb. 6.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
US cyber agency's future role in elections remains murky under the Trump administration
WASHINGTON (AP) — The nation’s cybersecurity agency has played in helping states shore up the defenses of their voting systems, but its election mission appears uncertain amid sustained criticism from Republicans and key figures in the Trump administration.
Did DeepSeek copy ChatGPT? Trump adviser thinks so
Did the upstart copy ChatGPT to make the artificial intelligence technology that this week?
Crypto Stocks Surge Amid Market Boom - Ad
Crypto stocks are on fire as Bitcoin hits all-time highs. One under-the-radar company is leading the charge, managing $2.1 billion in client assets and seeing record trading volumes. With crypto adoption skyrocketing, this could be a game-changing opportunity.
Betting Against Nvidia Again
So much for the Jevons paradox.
Wall Street's Most Accurate Analysts Weigh In On 3 Consumer Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
Is This Defi Coin Your Next "10-Bagger" Investment? - Ad
Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.
No, Spain isn't banning tourists. Here's what to know before planning a trip
MADRID (AP) — Spain , making the Southern European nation famous for its Mediterranean coastline, sweeping landscapes and historic cities among the most visited countries on earth.
Dan Ives Expects Meta And Microsoft To Stand Firm On $60 - $80 Billion AI Spending Plans Amid DeepSeek's Disruptive AI Model
Wedbush Securities analyst Dan Ives expects Meta Platforms Inc. and Microsoft Corp. to stand firm on their ambitious artificial intelligence spending plans during their upcoming earnings calls, despite recent market jitters over Chinese AI startup DeepSeek's emergence.
AI's NEXT Magnificent Seven - Ad
The original Magnificent Seven produced 16,894% average returns over 20 years. But the man who called Nvidia at $1.10 says "AI's next Magnificent Seven could do it even faster." See his breakdown of the seven stocks you should own here.
MrBeast's Net Worth Hits $1 Billion—But In 2023, He Promised To 'Give Away' All His Money. What Drives The YouTuber's Philanthropy?
MrBeast, who once defended his charity-driven content by pledging to give away all his money, has officially become a self-made billionaire with a $1 billion net worth, driven by his massive YouTube empire, merchandise sales, and a $100 million Amazon streaming deal.
Dubai's ceaseless boom is putting strains on its residents
DUBAI, United Arab Emirates (AP) — — and some residents are starting to feel burned.
Legendary Wall Street Stock Picker Names No.1 AI Stock of 2025 - Ad
Marc Chaikin's system has detected another bewildering trend in the U.S. stock market. And he says this stock could shoot sky-high in the new year as a direct result. To hear it for yourself, click here. You'll get this stock's name and ticker symbol, absolutely free.
Tesla's $30K EV Risks Being A 'Nothing Burger,' Says Gary Black—Warns Of Cannibalization Without A New Compact Design
Tesla Inc.'s planned $30,000 electric vehicle could disappoint investors if it fails to introduce a new compact form factor, according to prominent Tesla bull Gary Black, managing partner of The Future Fund LLC.
Japanese automaker Nissan says it plans job and production cuts in the U.S.
TOKYO (AP) — Nissan is slashing production at its U.S. plants and offering buyouts to factory workers there as part of the Japanese automaker’s urgent efforts to return to profitability.
Donald Trump to Repeal Joe Biden's AI Executive Order - Ad
This will open the floodgates! Once Donald Trump takes this decisive action, it will ignite a second wave of euphoria in AI stocks. And one company -- founded by Elon Musk, Trump's right-hand man and most trustworthy advisor -- is in the prime position to profit. (Hint: It's NOT Tesla).
Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need to know.
Donald and Melania Trump Memecoins Outgain Bitcoin, Ethereum Amid Market Lull -- Analyst Says TRUMP Bottomed Out At $25
President Donald Trump‘s meme coin outperformed the broader cryptocurrency market with a double-digit surge on Monday. What happened: The Official Trump (TRUMP) token surged over 10% in the last 24 hours, reaching a market valuation of $5.92 billion and a fully diluted value of $29.62 billion.
JFK, 9/11... And Now This? - Ad
Jim Rickards says we'll never forget April 11, 2025. Jim outlines a crash so terrible it may even have the power to wipe out the checking and savings accounts at your bank... Along with 40% of the market. Jim is one of America's best geopolitical analysts... All you need to know is in a quick summary of his latest book.
Microsoft reports 10% quarterly profit growth as it works to show AI investments paying off
REDMOND, Wash. (AP) — Microsoft Corp. said Wednesday that its profit for the October-December quarter grew 10% from the same time last year as it works to capitalize on the huge amounts of money it has spent to advance its artificial intelligence technology.
Legoland Florida plans to layoff 234 workers who are mostly performers
WINTER HAVEN, Fla. (AP) — plans to lay off 234 workers, primarily performers, in an effort to be more competitive in central Florida's thriving theme park market, company officials said.
He Called Bitcoin to $100k... Now He Says This Coin Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
Dubai International Airport, busiest for world travel, sees record 92.3 million passengers in 2024
DUBAI, United Arab Emirates (AP) — Dubai International Airport, the world's busiest for international travel, saw a record 92.3 million passengers pass through its terminals in 2024, officials announced Thursday.
Robert Kiyosaki Predicts Yet Another Stock Market Crash, Pitches Bitcoin Investments -- Here's What The 'Rich Dad Poor Dad' Author Said
Renowned investor and author Robert Kiyosaki on Monday predicted a major stock market crash in February and advised investors to focus on Bitcoin (CRYPTO: BTC), gold, and silver.
The $20 Stock Powering NVIDIA, TESLA, and Microsoft - Ad
The biggest AI firms in the world... All rely on this single company. And right now, you can get in for only $20 - but not for long.
'Mona Lisa' will get its own room under a major renovation of the Louvre
PARIS (AP) — French President Emmanuel Macron announced Tuesday that will get its own dedicated room inside the Louvre museum under a major renovation and expansion of the Paris landmark that will take up to a decade.
AI ETFs In Focus As Alibaba Challenges DeepSeek With New Model
AI arms race fueled by DeepSeek and Alibaba's AI models. Investors can profit from trend with AI-focused ETFs, including AIQ, ARKQ, QQQ.
Ex CIA Predicts 40% "Double Crash" -- April 11 - Ad
I strongly advise taking action ahead of this NEW kind of economic crash... What makes this new crash so uniquely dangerous is that it could erase bank accounts.... My best followers are already following the steps laid out in this video. Prepare now, or suffer when the market implodes by 40% in a single day as soon as April 11. You've been warned.
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating IBD.
UK Faces Triple Threat as Economic Uncertainty Hits
The United Kingdom faces a decline in stock market listings, demographic crisis, and diminishing tax revenue with an exodus of high earners.
Legendary Investor: Buy These "Trump Stocks" Now - Ad
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
Nvidia Stock Slides Overnight On Robinhood As China's DeepSeek Sparks Doubts Over GPU Spending Frenzy — Chamath Palihapitiya Highlights Report Indicating AI Holy Grail Cracked
Nvidia shares fell 3.12% after China's DeepSeek unveiled an AI model that delivers cutting-edge performance at a fraction of the cost, raising concerns over the necessity of massive GPU-related spending.
Bank of America's Sensitive Customer Data Compromised in Third-Party Hack - Is Your Account Safe?
Bank of America (NYSE: BAC) has confirmed a data breach involving a third-party software provider that led to the exposure of sensitive customer data.
5-Second Trump Clip will Give You Chills - Ad
If you have any money in the markets, take a moment to see this presentation with a 5-second clip of a shocking prediction President Trump made during his victory speech... Because according to legendary investor Louis Navellier, who correctly predicted Trump's win... This prediction is about to become a reality.
Despite chaos over Trump White House's funding pause, FAFSA forms and student loans still available
A temporary freeze imposed briefly this week by the White House on federal grants and loans left many students wondering about the impact to the used to apply for financial aid.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.